|
GB0031579D0
|
|
Pharmaceutical compounds
|
|
GB0027678D0
|
|
Pharmaceutical compounds
|
|
GB0019290D0
|
|
Methods for inducing apolipoprotein E secretion
|
|
GB0019272D0
|
|
Pharmaceutical compounds
|
|
GB0012529D0
|
|
Apolipoprotein e modulators
|
|
GB0012534D0
|
|
Pharmaceutical compounds
|
|
CZ219699A3
|
|
Pharmaceutical derivatives of aminophosphonic acid
|
|
GB9626615D0
|
|
Novel compounds
|
|
GB9626616D0
|
|
Novel compounds
|
|
GB9626536D0
|
|
Novel compounds
|
|
GB9626617D0
|
|
Novel compounds
|
|
CH690163A5
|
|
Derivatives substituted gem-diphosphonates useful as anti-cancer.
|
|
CH690264A5
|
|
aminophosphonates substituted derivatives, their preparation process and their use for preparing pharmaceutical compositions.
|
|
ZA9401088B
|
|
Substituted ketophosphonates the processes for their preparation and pharmaceutical compositions containing them
|
|
US5204336A
|
|
Naphthyl-,tetrahydronaphthyl-, and indanyl-substituted G-em-diphosphonates and process of use to treat hyperlipidemia
|
|
CH683996A5
|
|
aminophosphonates substituted derivatives, process for their preparation and pharmaceutical compositions containing them.
|
|
AU6234590A
|
|
Naphthalene and tetrahydronaphthalene substituted gem- diphosphonate compounds and their use in therapy
|
|
GB8920861D0
|
|
Compounds
|
|
GB8920860D0
|
|
Compounds
|
|
IE890802L
|
|
Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them
|
